Tandem Diabetes Care Inc operates in the Surgical and medical instruments sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Tandem Diabetes Care Inc with three other
companies in this sector in the United States:
sales of $156.47 million
of which 100%
was License Fee),
Orasure Technologies Incorporated
of which 53%
was DNGA), and
of which 36%
was Open-Heart Ablation).
Tandem Diabetes Care Inc reported sales of $183.87 million
December of 2018.
increase of 70.9%
versus 2017, when the company's sales were $107.60 million.
Sales at Tandem Diabetes Care Inc have increased during each of the previous five years
(and since 2013, sales have increased a total of 534%).